PBC
PBC (PBC) is a company in Vietnam's Health Care sector, listed on UPCOM. The stock last traded at 5,300 VND, little changed on the session, giving a market capitalization of 618.5 billion VND.
On valuation, PBC trades at a price-to-earnings ratio of 14.9 and a price-to-book of 0.5. That is a discount to the Health Care sector average P/E of 19.4. Return on equity of 3.1% points to weak profitability relative to the company's equity base, below the sector average of 11.3%. Trailing earnings per share stand at 348 VND.
Aveluro tracks 2 news items mentioning PBC, where recent coverage skews negative (100% of articles). The most recent catalyst was a legal action event — "Pharbaco CEO fined 524M VND, banned 18 months for unreported share purchase".
Comparable names in the Health Care sector include AGP, AMP and AMV.
Pharbaco CEO fined 524M VND, banned 18 months for unreported share purchase
Recent developments around PBC include 2 notable classified events. On Aug 19, 2026, a market event was reported: Pharbaco (PBC) CEO Nguyễn Đình Tuấn was fined nearly 524 million VND and banned from securities trading for 18 months after failing to report a purchase of 3.49 million shares on April 28, 2026. A recent a market event was reported: Pharbaco (PBC) CEO Nguyen Dinh Tuan was fined 523.7 million VND and suspended from securities trading for 18 months after failing to report a planned purchase of nearly 3.5 million PBC shares on April 28, 2026.
The overall tone of recent coverage is negative, with 2 of 2 events carrying bearish sentiment.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this